聯(lián)系我們
電話：010-80493132
Email：BPI@genomics.org.cn??
HuProt?人全蛋白質組芯片
HuProt? HuProtTM V4.0芯片上有超過2萬個釀酒酵母表達, 帶有GST和His標簽的重組人蛋白和部分小鼠重要蛋白, 其中89%為全長蛋白,涉及約17000個人類基因和124種鼠對照蛋白。酵母蛋白具有翻譯后修飾, 故也適用于PTM研究。非接觸噴印 (Arrayjet Non-Contact Piezoelectric Print) 保證了樣品點均勻度和復點間一致性, 分析結果更準確。
 |
 |
檢測時，分析物（Analyte）先與芯片孵育, 并與特定蛋白結合。分析物是血液IgG或雜交瘤培養(yǎng)上清時, 使用熒光標記的抗人(鼠)IgG抗體即可檢出結合的IgG, 對其他分子則通過標記分析物或其抗體的方式檢測，熒光掃描芯片取得數(shù)據(jù)后用于分析, 后續(xù)針對初篩得到的蛋白定制小規(guī)模芯片進行大樣本驗證。
 |
Humoral immune response to tumor-associated antigen Ubiquilin 1 (UBQLN1) and its tumor-promoting potential in lung cancer. BMC Cancer.2024 Deoxyhypusine hydroxylase as a novel pharmacological target for ischemic stroke via inducing a unique post-translational hypusination
A novel enzyme-linked ligand-sorbent assay (ELLSA) to screening pulmonary tuberculosis: a retrospective cross-sectional study. Microbes Infect.2023 ASPSCR-1 and Sirt-5 alleviate Clonorchis liver fluke rCsNOSIP-induced oxidative stress, proliferation, and migration in cholangiocarcinoma cells. PLoS Negl Trop Dis. 2023 Exploration of the Hsa-miR-1587-Protein Interaction and the Inhibition to CASK. Int J Mol Sci.2021
Sodium danshensu attenuates cerebral ischemia-reperfusion injury by targeting AKT1.Front Pharmacol.2021 |
|
文獻題名 |
發(fā)表刊物 |
發(fā)表年份 |
研究類型 |
|
Circulating autoantibody profiling identifies LIMS1 as a potential target for pathogenic autoimmunity in pathologic myopia. |
Mol Cell Proteomics |
2024 |
自身抗體鑒定 |
|
High-Throughput Antigen Microarray Identifies Longitudinal Prognostic Autoantibody for Chemoimmunotherapy in Advanced Non-Small Cell Lung Cancer. |
Mol Cell Proteomics |
2024 |
腫瘤自身抗體 |
|
Humoral immune response to tumor-associated antigen Ubiquilin 1 (UBQLN1) and its tumor-promoting potential in lung cancer. |
BMC Cancer |
2024 |
腫瘤自身抗體 |
|
Proteome microarray identifies autoantibody biomarkers for diagnosis of hepatitis B-related hepatocellular carcinoma. |
Clin Chim Acta |
2024 |
腫瘤自身抗體 |
|
A novel enzyme-linked ligand-sorbent assay (ELLSA) to screening pulmonary tuberculosis: a retrospective cross-sectional study. |
Microbes Infect |
2023 |
互作蛋白鑒定 |
|
A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma. |
Cancer Cell Int |
2023 |
腫瘤自身抗體 |
|
ASPSCR-1 and Sirt-5 alleviate Clonorchis liver fluke rCsNOSIP-induced oxidative stress, proliferation, and migration in cholangiocarcinoma cells. |
PLoS Negl Trop Dis |
2023 |
互作蛋白鑒定 |
|
Identification of Anti-SNRPA as a Novel Serological Biomarker for Systemic Sclerosis Diagnosis. |
J Proteome Res |
2023 |
自身抗體鑒定 |
|
Autoantibody screening of plasma and peritoneal fluid of patients with endometriosis. |
Hum Reprod |
2023 |
自身抗體鑒定 |
|
Circulating tumor-associated autoantibodies as novel diagnostic biomarkers in pancreatic adenocarcinoma. |
Int J Cancer |
2023 |
腫瘤自身抗體 |
|
Identification of novel serological autoantibodies in Chinese prostate cancer patients using high-throughput protein arrays. |
Cancer Immunol Immunother |
2022 |
腫瘤自身抗體 |
|
Characteristics of Serum Autoantibody Repertoire and Immune Subgroup Variation of Tuberculosis-Associated Obstructive Pulmonary Disease. |
Int J Chron Obstruct Pulmon Dis |
2022 |
自身抗體鑒定 |
|
Serum Biomarker Panel for Rapid Early Diagnosis of Lung Cancer. |
Curr Cancer Drug Targets |
2022 |
腫瘤自身抗體 |
|
Diagnostic value of anti-Kaiso autoantibody in axial spondyloarthritis. |
Front Immunol |
2022 |
自身抗體鑒定 |
|
Autoantibody signatures discovered by HuProt protein microarray to enhance the diagnosis of lung cancer. |
Clin Immunol |
2022 |
腫瘤自身抗體 |
|
Evaluation of autoantibody signatures in pituitary adenoma patients using human proteome arrays. |
Proteomics Clin Appl |
2022 |
自身抗體鑒定 |
|
Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade. |
Clin Cancer Res |
2022 |
抗體治療監(jiān)測 |
|
Temporal reproducibility of IgG and IgM autoantibodies in serum from healthy women. |
Sci Rep |
2022 |
血清抗體監(jiān)測 |
|
Deoxyhypusine hydroxylase as a novel pharmacological target for ischemic stroke via inducing a unique post-translational hypusination modification. |
Pharmacol Res |
2022 |
藥物靶點鑒定 |
|
A combination of multiple autoantibodies is associated with the risk of Alzheimer's disease and cognitive impairment. |
Sci Rep |
2021 |
神經(jīng)退行性疾病 |
|
Sodium danshensu attenuates cerebral ischemia-reperfusion injury by targeting AKT1. |
Front Pharmacol |
2021 |
藥物靶點鑒定 |
|
Multiple rather than specific autoantibodies were identified in irritable bowel syndrome with HuProt? proteome microarray. |
Front Physiol |
2021 |
自身抗體鑒定 |
|
Exploration of the Hsa-miR-1587-Protein Interaction and the Inhibition to CASK. |
Int J Mol Sci |
2021 |
互作蛋白鑒定 |
|
CIDP Antibodies Target Junction Proteins and Identify Patient Subgroups: An Autoantigenomic Approach. |
Neurol Neuroimmunol Neuroinflamm |
2021 |
神經(jīng)類疾病自身抗體 |
版權所有 ? 北京華大蛋白質研發(fā)中心有限公司 京ICP備10024265號-4
京公網(wǎng)安備 11011302002842號
網(wǎng)站建設：中企動力 北京
